{
  "abstract": "Primary aldosteronism (PA) is a systemic endocrine tumor disease driven by somatic-mutation-defined aldosterone-producing lesions. In most unilateral cases, adrenalectomy achieves biochemical cure and restores mortality to that of the general population. However, diagnostic delay, limited access to adrenal venous sampling (AVS) and specialized surgery, and bilateral or non-operable disease mean that many patients require lifelong pharmacological therapy and structured surveillance. This review proposes a severity-stratified framework for diagnosis, targeted treatment, and long-term surveillance around four pillars: (1) early and expanded screening, stratified by pretest probability and severity; (2) precision subtyping, with surgical candidacy and patient preference as the first decision node, integrated with probability-based pathways, Primary Aldosteronism Severity Classification (PASC) grading, molecular and genetic subtyping, and cortisol co-secretion screening; (3) targeted source elimination (adrenalectomy) or mineralocorticoid receptor (MR) blockade, with plasma renin reactivation proposed as a candidate pharmacodynamic marker rather than a validated endpoint; and (4) structured long-term surveillance, with basic assessments universal and advanced imaging reserved for high-risk patients or research protocols. For each pillar, we distinguish guideline-based recommendations from expert consensus and research-oriented components, and identify key evidence gaps. We critically appraise 2025–2026 guidelines and emerging evidence on molecular imaging, patient-reported outcomes, and novel agents. The framework translates pathophysiological insights into an actionable, organ-protection-centered pathway while remaining explicit about what is known, assumed, and still unproven; several components—renin-guided MR antagonist titration, AVS-bypass strategies, and advanced follow-up imaging—remain hypothesis-generating and require prospective validation.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Urology, First Affiliated Hospital of Gannan Medical University"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 6,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Jianxin Gong"
    },
    {
      "affs": [
        0
      ],
      "name": "Yue Wang"
    },
    {
      "affs": [
        0
      ],
      "name": "Jiaqiang Gui"
    },
    {
      "affs": [
        0
      ],
      "name": "Haiye Fan"
    },
    {
      "affs": [
        0
      ],
      "name": "Xiaofeng Zou"
    },
    {
      "affs": [
        0
      ],
      "name": "Tianpeng Xie"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/8mn14e3mq88jm.bib",
  "cited_by": 0,
  "doi": "10.3389/fendo.2026.2023718",
  "fulltext_url": null,
  "id": "8mn14e3mq88jm",
  "issns": [
    "1664-2392"
  ],
  "landing_url": "https://www.frontiersin.org/articles/10.3389/fendo.2026.2023718/full",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-16",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/8mn14e3mq88jm.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:26:02Z",
      "native_id": "10.3389/fendo.2026.2023718",
      "source": "crossref",
      "url": "https://www.frontiersin.org/articles/10.3389/fendo.2026.2023718/full"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "issn:1664-2392",
      "subfield": "endocrinology-metabolism"
    }
  ],
  "title": "Primary aldosteronism as a systemic endocrine tumor disease: a severity-stratified framework for diagnosis, targeted treatment, and long-term surveillance",
  "title_text": "Primary aldosteronism as a systemic endocrine tumor disease: a severity-stratified framework for diagnosis, targeted treatment, and long-term surveillance",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:26:02Z",
  "url": "https://research.draconitic.com/paper/8mn14e3mq88jm",
  "venue": "Frontiers in Endocrinology",
  "versions": []
}